{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T16:58:16Z","timestamp":1776704296347,"version":"3.51.2"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2015,7,7]],"date-time":"2015-07-07T00:00:00Z","timestamp":1436227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation, Berne, Switzerland","doi-asserted-by":"publisher","award":["320030_141216"],"award-info":[{"award-number":["320030_141216"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8,13]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Volatile anaesthetics such as sevoflurane attenuate inflammatory processes, thereby impacting patient outcome significantly. Their inhalative administration is, however, strictly limited to controlled environments such as operating theatres, and thus an intravenously injectable immunomodulatory drug would offer distinct advantages. As protective effects of volatile anaesthetics have been associated with the presence of trifluorinated carbon groups in their basic structure, in this study we investigated the water-soluble sevoflurane metabolite hexafluoro-2-propanol (HFIP) as a potential immunomodulatory drug in a rat model of endotoxic shock. Male Wistar rats were subjected to intravenous lipopolysaccharide (LPS) and thereafter were treated with HFIP. Plasma and tissue inflammatory mediators, neutrophil invasion, tissue damage and haemodynamic stability were the dedicated end-points. In an endotoxin-induced endothelial cell injury model, underlying mechanisms were elucidated using gene expression and gene reporter analyses. HFIP reduced the systemic inflammatory response significantly and decreased endotoxin-induced tissue damage. Additionally, the LPS-provoked drop in blood pressure of animals was resolved by HFIP treatment. Pathway analysis revealed that the observed attenuation of the inflammatory process was associated with reduced nuclear factor kappa B (NF-\u03ba\u0392) activation and suppression of its dependent transcripts. Taken together, intravenous administration of HFIP exerts promising immunomodulatory effects in endotoxaemic rats. The possibility of intravenous administration would overcome limitations of volatile anaesthetics, and thus HFIP might therefore represent an interesting future drug candidate for states of severe inflammation.<\/jats:p>","DOI":"10.1111\/cei.12648","type":"journal-article","created":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T20:57:09Z","timestamp":1430341029000},"page":"468-479","source":"Crossref","is-referenced-by-count":12,"title":["Insight into the beneficial immunomodulatory mechanism of the sevoflurane metabolite hexafluoro-2-propanol in a rat model of endotoxaemia"],"prefix":"10.1093","volume":"181","author":[{"given":"M","family":"Urner","sequence":"first","affiliation":[{"name":"Institute of Anesthesiology, University Hospital Zurich, Zurich, Switzerland"},{"name":"Institute of Physiology, Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Schl\u00e4pfer","sequence":"additional","affiliation":[{"name":"Institute of Anesthesiology, University Hospital Zurich, Zurich, Switzerland"},{"name":"Institute of Physiology, Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I K","family":"Herrmann","sequence":"additional","affiliation":[{"name":"Institute of Anesthesiology, University Hospital Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Hasler","sequence":"additional","affiliation":[{"name":"Institute of Anesthesiology, University Hospital Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R R","family":"Schimmer","sequence":"additional","affiliation":[{"name":"Institute of Physiology, Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Booy","sequence":"additional","affiliation":[{"name":"Institute of Anesthesiology, University Hospital Zurich, Zurich, Switzerland"},{"name":"Institute of Physiology, Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Roth Z'graggen","sequence":"additional","affiliation":[{"name":"Institute of Physiology, Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland"},{"name":"Functional Genomics Center Zurich, University of Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Rehrauer","sequence":"additional","affiliation":[{"name":"Functional Genomics Center Zurich, University of Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Aigner","sequence":"additional","affiliation":[{"name":"Institute of Physiology, Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R D","family":"Minshall","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University of Illinois Chicago, Chicago, IL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W J","family":"Stark","sequence":"additional","affiliation":[{"name":"Institute for Chemical and Bioengineering, Department of Chemistry and Applied Biosciences, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Beck-Schimmer","sequence":"additional","affiliation":[{"name":"Institute of Anesthesiology, University Hospital Zurich, Zurich, Switzerland"},{"name":"Institute of Physiology, Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland"},{"name":"Department of Anesthesiology, University of Illinois Chicago, Chicago, IL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,7,7]]},"reference":[{"key":"2021122010154979800_cei12648-bib-0001","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/CCM.0b013e318232db65","article-title":"Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007","volume":"40","author":"Lagu","year":"2012","journal-title":"Crit Care Med"},{"key":"2021122010154979800_cei12648-bib-0002","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/CCM.0b013e3181cc4824","article-title":"Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department","volume":"38","author":"Gaieski","year":"2010","journal-title":"Crit Care Med"},{"key":"2021122010154979800_cei12648-bib-0003","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012","volume":"41","author":"Dellinger","year":"2013","journal-title":"Crit Care Med"},{"key":"2021122010154979800_cei12648-bib-0004","first-page":"269","article-title":"Cardiac protection by volatile anesthetics. A review","volume":"75","author":"Landoni","year":"2009","journal-title":"Minerva Anestesiol"},{"key":"2021122010154979800_cei12648-bib-0005","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/SLA.0b013e31818f3dda","article-title":"A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic","volume":"248","author":"Beck-Schimmer","year":"2008","journal-title":"Ann Surg"},{"key":"2021122010154979800_cei12648-bib-0006","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1749-6632.1992.tb49147.x","article-title":"Conditioning of immune response by anesthetics","volume":"650","author":"Ferrero","year":"1992","journal-title":"Ann NY Acad Sci"},{"key":"2021122010154979800_cei12648-bib-0007","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/ALN.0b013e3182a2a3a4","article-title":"Sleeping to survive? The impact of volatile anesthetics on mortality in sepsis","volume":"119","author":"Kharasch","year":"2013","journal-title":"Anesthesiology"},{"key":"2021122010154979800_cei12648-bib-0008","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1097\/ALN.0b013e3181a10731","article-title":"Anesthetic-induced improvement of the inflammatory response to one-lung ventilation","volume":"110","author":"De Conno","year":"2009","journal-title":"Anesthesiology"},{"key":"2021122010154979800_cei12648-bib-0009","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1097\/00000542-200306000-00004","article-title":"Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study","volume":"98","author":"Julier","year":"2003","journal-title":"Anesthesiology"},{"key":"2021122010154979800_cei12648-bib-0010","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/ALN.0b013e3182a2a38c","article-title":"Volatile anesthetics improve survival after cecal ligation and puncture","volume":"119","author":"Herrmann","year":"2013","journal-title":"Anesthesiology"},{"key":"2021122010154979800_cei12648-bib-0011","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.shk.0000248595.17130.24","article-title":"Isoflurane improves survival and protects against renal and hepatic injury in murine septic peritonitis","volume":"27","author":"Lee","year":"2007","journal-title":"Shock"},{"key":"2021122010154979800_cei12648-bib-0012","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1213\/ane.0b013e31816d1661","article-title":"Emulsified intravenous versus evaporated inhaled isoflurane for heart protection: old wine in a new bottle or true innovation?","volume":"106","author":"Lucchinetti","year":"2008","journal-title":"Anesth Analg"},{"key":"2021122010154979800_cei12648-bib-0013","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1165\/rcmb.2010-0451OC","article-title":"Fluorinated groups mediate the immunomodulatory effects of volatile anesthetics in acute cell injury","volume":"45","author":"Urner","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2021122010154979800_cei12648-bib-0014","doi-asserted-by":"crossref","first-page":"e72057","DOI":"10.1371\/journal.pone.0072057","article-title":"Intravenous application of a primary sevoflurane metabolite improves outcome in murine septic peritonitis: first results","volume":"8","author":"Herrmann","year":"2013","journal-title":"PLOS ONE"},{"key":"2021122010154979800_cei12648-bib-0015","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1172\/JCI39421","article-title":"Animal models of sepsis and sepsis-induced kidney injury","volume":"119","author":"Doi","year":"2009","journal-title":"J Clin Invest"},{"key":"2021122010154979800_cei12648-bib-0016","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0952-7915(99)00046-1","article-title":"Tlr4: central component of the sole mammalian LPS sensor","volume":"12","author":"Beutler","year":"2000","journal-title":"Curr Opin Immunol"},{"key":"2021122010154979800_cei12648-bib-0017","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/41131","article-title":"A human homologue of the Drosophila toll protein signals activation of adaptive immunity","volume":"388","author":"Medzhitov","year":"1997","journal-title":"Nature"},{"key":"2021122010154979800_cei12648-bib-0018","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1097\/ALN.0b013e3181bdf857","article-title":"Sevoflurane ameliorates gas exchange and attenuates lung damage in experimental lipopolysaccharide-induced lung injury","volume":"111","author":"Voigtsberger","year":"2009","journal-title":"Anesthesiology"},{"key":"2021122010154979800_cei12648-bib-0019","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1165\/rcmb.2010-0451OC","article-title":"Fluorinated groups mediate the immunomodulatory effects of volatile anesthetics in acute cell injury","volume":"45","author":"Urner","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2021122010154979800_cei12648-bib-0020","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1097\/00000542-199506000-00008","article-title":"Clinical sevoflurane metabolism and disposition. I. Sevoflurane and metabolite pharmacokinetics","volume":"82","author":"Kharasch","year":"1995","journal-title":"Anesthesiology"},{"key":"2021122010154979800_cei12648-bib-0021","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1186\/cc5783","article-title":"Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis","volume":"11","author":"Bozza","year":"2007","journal-title":"Crit Care"},{"key":"2021122010154979800_cei12648-bib-0022","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00000658-199204000-00009","article-title":"Cytokine serum level during severe sepsis in human IL-6 as a marker of severity","volume":"215","author":"Damas","year":"1992","journal-title":"Ann Surg"},{"key":"2021122010154979800_cei12648-bib-0023","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1186\/cc4836","article-title":"CC and CXC chemokine levels in children with meningococcal sepsis accurately predict mortality and disease severity","volume":"10","author":"Vermont","year":"2006","journal-title":"Crit Care"},{"key":"2021122010154979800_cei12648-bib-0024","first-page":"347","article-title":"Neutrophil depletion protects against liver injury from bacterial endotoxin","volume":"66","author":"Hewett","year":"1992","journal-title":"Lab Invest"},{"key":"2021122010154979800_cei12648-bib-0025","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1378\/chest.127.3.942","article-title":"Incidence and impact of organ dysfunctions associated with sepsis","volume":"127","author":"Guidet","year":"2005","journal-title":"Chest"},{"key":"2021122010154979800_cei12648-bib-0026","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/sj.ki.5000165","article-title":"Sepsis-induced organ failure is mediated by different pathways in the kidney and liver: acute renal failure is dependent on MyD88 but not renal cell apoptosis","volume":"69","author":"Dear","year":"2006","journal-title":"Kidney Int"},{"key":"2021122010154979800_cei12648-bib-0027","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nri2402","article-title":"Harmful molecular mechanisms in sepsis","volume":"8","author":"Rittirsch","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"2021122010154979800_cei12648-bib-0028","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1681\/ASN.2013010019","article-title":"Analysis of a urinary biomarker panel for incident kidney disease and clinical outcomes","volume":"24","author":"O'Seaghdha","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"2021122010154979800_cei12648-bib-0029","doi-asserted-by":"crossref","first-page":"7847","DOI":"10.1016\/S0021-9258(18)34459-4","article-title":"Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters","volume":"257","author":"Castagna","year":"1982","journal-title":"J Biol Chem"},{"key":"2021122010154979800_cei12648-bib-0030","first-page":"1","article-title":"Protein kinase C as the receptor for the phorbol ester tumor promoters: sixth Rhoads memorial award lecture","volume":"48","author":"Blumberg","year":"1988","journal-title":"Cancer Res"},{"key":"2021122010154979800_cei12648-bib-0031","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1097\/ALN.0b013e3181bdf857","article-title":"Sevoflurane ameliorates gas exchange and attenuates lung damage in experimental lipopolysaccharide-induced lung injury","volume":"111","author":"Voigtsberger","year":"2009","journal-title":"Anesthesiology"},{"key":"2021122010154979800_cei12648-bib-0032","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.4049\/jimmunol.166.11.6952","article-title":"Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans","volume":"166","author":"Hotchkiss","year":"2001","journal-title":"J Immunol"},{"key":"2021122010154979800_cei12648-bib-0033","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nri1943","article-title":"Apoptosis and caspases regulate death and inflammation in sepsis","volume":"6","author":"Hotchkiss","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"2021122010154979800_cei12648-bib-0034","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/6514","article-title":"Neuroprotection by a caspase inhibitor in acute bacterial meningitis","volume":"5","author":"Braun","year":"1999","journal-title":"Nat Med"},{"key":"2021122010154979800_cei12648-bib-0035","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/82741","article-title":"Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte","volume":"1","author":"Hotchkiss","year":"2000","journal-title":"Nat Immunol"},{"key":"2021122010154979800_cei12648-bib-0036","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/00000542-200403000-00012","article-title":"Nuclear factor kappaB and anesthetic preconditioning during myocardial ischemia\u2013reperfusion","volume":"100","author":"Zhong","year":"2004","journal-title":"Anesthesiology"},{"key":"2021122010154979800_cei12648-bib-0037","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/00000542-200409000-00020","article-title":"Sevoflurane inhibits phorbol-myristate-acetate-induced activator protein-1 activation in human T lymphocytes in vitro: potential role of the p38-stress kinase pathway","volume":"101","author":"Loop","year":"2004","journal-title":"Anesthesiology"},{"key":"2021122010154979800_cei12648-bib-0038","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nrd1854","article-title":"Animal models of sepsis: setting the stage","volume":"4","author":"Buras","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"2021122010154979800_cei12648-bib-0039","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00003246-199707000-00001","article-title":"Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment","volume":"25","author":"Zeni","year":"1997","journal-title":"Crit Care Med"},{"key":"2021122010154979800_cei12648-bib-0040","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1097\/01.CCM.0000145231.71605.D8","article-title":"Hospital mortality and resource use in subgroups of the recombinant human activated protein C worldwide evaluation in severe sepsis (PROWESS) trial","volume":"32","author":"Laterre","year":"2004","journal-title":"Crit Care Med"},{"key":"2021122010154979800_cei12648-bib-0041","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/ALN.0b013e3182a2a3a4","article-title":"Sleeping to survive?: The impact of volatile anesthetics on mortality in sepsis","volume":"119","author":"Kharasch","year":"2013","journal-title":"Anesthesiology"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.12648","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/181\/3\/468\/41791649\/cei12648.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/181\/3\/468\/41791649\/cei12648.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:26:41Z","timestamp":1641054401000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/181\/3\/468\/6422135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,7]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,7,7]]},"published-print":{"date-parts":[[2015,8,13]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.12648","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,9]]},"published":{"date-parts":[[2015,7,7]]}}}